Understand Any US Earnings Report in 60 Seconds

JPMorgan Chase

JPMorgan Chase reported a 41% surge in net income to $21.2 billion in Q2 FY2026, fueled by a $4.6 billion Visa gain and strong trading and investment banking results, while expenses and credit provisions also rose.

Lilly (Eli)

Lilly's Q2 FY2026 results were driven by incretin demand, with Mounjaro and Zepbound fueling revenue growth, while heavy investment in acquisitions and pipeline expansion weighed on profitability.

Advanced Micro Devices

AMD's fiscal second quarter revenue jumped 50% and gross margin reached 54%, propelled by a doubling of Data Center sales, while operating expenses rose sharply to fund AI expansion.

Procter & Gamble

P&G reported flat organic volume growth and margin compression in FY2026, with operating income down 3% despite a 3% increase in reported net sales, as the company invested heavily in marketing and product superiority.

AbbVie

AbbVie's Q2 FY2026 results showcased strong double-digit revenue growth driven by immunology products, while net income soared due to reduced non-cash charges, though Humira decline and regulatory risks remain.

ExxonMobil

ExxonMobil’s Q2 FY2026 net income skyrocketed to $14.5 billion, propelled by higher commodity prices, record refining margins, and disciplined cost management, despite substantial one-time charges and Middle East supply disruptions.

Apple Inc.

Apple delivered double-digit revenue growth in Q3 FY2026, powered by iPhone and Services, but warned that escalating component costs and tariff headwinds may pressure margins ahead.

Amazon

Amazon's Q2 FY2026 earnings featured robust AWS growth and strong operating leverage, while net income was substantially inflated by $53.4B in Anthropic investment gains.